AZTR Azitra, Inc.

BEARISH Impact: 7/10 EFFECT
Horizon immediate Filed Jun 3, 2026 Processed 2d 11h ago SEC 9999999995-26-001854
IPO/offering going effective

Price Chart

Loading chart...

Executive Summary

The SEC declared effective Azitra's S-1 registration statement (File No. 333-296125) on June 2, 2026, covering the resale of up to 255.7 million shares (526% of outstanding) held by selling stockholders from a prior private placement. The company receives no proceeds from share resales but could collect up to ~$21M if warrants are exercised for cash. With a going concern opinion, $2.0M working capital, and only ~9 months of cash runway, this effectiveness unlocks massive potential dilution overhang.

Actionable Insight

The effectiveness of this massive resale registration creates severe near-term dilution overhang. Expect continued downward pressure on AZTR as selling stockholders can immediately begin distributing shares into the market. Monitor for any NYSE delisting notice or further cash burn updates — the going concern risk is acute.

Key Facts

  • Effectiveness date: June 2, 2026 for S-1 File No. 333-296125
  • Registration covers up to 255.7 million shares — 526% of current outstanding shares
  • Shares registered for resale by selling stockholders from a March 2026 private placement; company receives no proceeds from resales
  • Company may receive up to ~$21M if warrants are exercised for cash, but this is contingent and uncertain
  • Prior S-1 (Dec 2025) also registered massive dilution from ELOC and November warrants; this effectiveness adds to the overhang
  • Company has a going concern opinion, $2.0M working capital, and ~9 months of cash runway
  • NYSE non-compliance adds further downside risk

Financial Impact

Potential dilution of 526% of current shares outstanding; company receives no proceeds from resales; contingent warrant cash proceeds up to ~$21M

dilutionworking capitalcash runwaygoing concern

Risk Factors

  • Immediate dilution overhang of 526% of outstanding shares
  • Selling stockholders can begin reselling immediately, pressuring the stock
  • Going concern opinion with only ~9 months of cash runway
  • NYSE non-compliance could lead to delisting
  • Contingent warrant cash proceeds are uncertain and may not materialize

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001854
Document: 9999999995-26-001854-index.html9999999995-26-001854
Document: 9999999995-26-001854.txt9999999995-26-001854
3 reports for AZTR
Performance horizon
Filters
Rows
Reports for AZTR — sortable, filterable
Type Now
Jun 3, 2026
2d ago
EFFECT
BEARISH ★ 7/10
awaiting T+60
May 21, 2026
15d ago
S-1
BEARISH ★ 6/10
awaiting T+60
Mar 5, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$0.1800 $0.2240▲ +24.44%▲ +11.66%$0.2111 (+17.28%)
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (64h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access